These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer's Disease. Viola KL; Bicca MA; Bebenek AM; Kranz DL; Nandwana V; Waters EA; Haney CR; Lee M; Gupta A; Brahmbhatt Z; Huang W; Chang TT; Peck A; Valdez C; Dravid VP; Klein WL Front Neurosci; 2021; 15():768646. PubMed ID: 35046767 [TBL] [Abstract][Full Text] [Related]
24. Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse. Takamura A; Okamoto Y; Kawarabayashi T; Yokoseki T; Shibata M; Mouri A; Nabeshima T; Sun H; Abe K; Urisu T; Yamamoto N; Shoji M; Yanagisawa K; Michikawa M; Matsubara E Mol Neurodegener; 2011 Mar; 6(1):20. PubMed ID: 21375782 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-β peptide oligomers. Nunes-Tavares N; Santos LE; Stutz B; Brito-Moreira J; Klein WL; Ferreira ST; de Mello FG J Biol Chem; 2012 Jun; 287(23):19377-85. PubMed ID: 22505713 [TBL] [Abstract][Full Text] [Related]
26. ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer's Disease. Krafft GA; Jerecic J; Siemers E; Cline EN Front Neurosci; 2022; 16():848215. PubMed ID: 35557606 [TBL] [Abstract][Full Text] [Related]
27. Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer's disease. Taniguchi K; Yamamoto F; Amano A; Tamaoka A; Sanjo N; Yokota T; Kametani F; Araki W Neurosci Res; 2022 Jul; 180():90-98. PubMed ID: 35257837 [TBL] [Abstract][Full Text] [Related]
28. Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid β aggregates in vivo in a mouse model of Alzheimer's disease. Calvo-Rodriguez M; Kharitonova EK; Snyder AC; Hou SS; Sanchez-Mico MV; Das S; Fan Z; Shirani H; Nilsson KPR; Serrano-Pozo A; Bacskai BJ Mol Neurodegener; 2024 Jan; 19(1):6. PubMed ID: 38238819 [TBL] [Abstract][Full Text] [Related]
29. The Toxicity and Polymorphism of β-Amyloid Oligomers. Huang YR; Liu RT Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599696 [TBL] [Abstract][Full Text] [Related]
30. Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer's Disease Model Mice. Taniguchi K; Yamamoto F; Arai T; Yang J; Sakai Y; Itoh M; Mamada N; Sekiguchi M; Yamada D; Saitoh A; Kametani F; Tamaoka A; Araki YM; Wada K; Mizusawa H; Araki W J Alzheimers Dis; 2019; 70(3):937-952. PubMed ID: 31227651 [TBL] [Abstract][Full Text] [Related]
31. Beta-amyloid, neuronal death and Alzheimer's disease. Carter J; Lippa CF Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259 [TBL] [Abstract][Full Text] [Related]